US Patent

US10231961 — Pharmaceutical compositions and methods of using the same

Formulation · Assigned to Genus Lifesciences Inc · Expires 2037-02-07 · 11y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those compositions.

USPTO Abstract

Novel pharmaceutical compositions including cocaine hydrochloride and methods of treating patients using those pharmaceutical compositions are described.

Drugs covered by this patent

cocaine-hydrochloride (COCAINE HYDROCHLORIDE)

Patent Metadata

Patent number: US10231961
Jurisdiction: US
Classification: Formulation
Expires: 2037-02-07
Drug substance claim: No
Drug product claim: Yes
Assignee: Genus Lifesciences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.